ABOS
ABOS
US00509G2093
Acumen Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
123.832.000 114.017.000
8.6%
Operating Income -123.832.000 -114.017.000
8.6%
Pretax Income -121.335.000 -102.329.000
18.6%
Net Income Common Stockholders -121.335.000 -102.329.000
18.6%
-- --
--
-- --
--
ende